NASDAQ · Biotechnology

Qualigen Therapeutics, Inc. (QLGN) Stock

$3.21 +5.59% NASDAQ: QLGN Healthcare

Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases.

Valuation

MetricValue
Price$3.21
Market Cap$5.43M
P/E Ratio-0.45
P/B Ratio1.13
P/S Ratio0.00
EPS (TTM)$-8.11
52-Week High$8.81
52-Week Low$1.61
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-105.92%
ROA-96.07%
ROCE-67.72%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio11.57

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$5.0M$5.0M$0$0
Operating Profit$-23.0M$-18.0M$-11.0M$-6.0M$-13.0M
Net Profit$-18.0M$-21.0M$-13.0M$-6.0M$-20.0M
EPS$-6.10$-5.48$-2.46$-17.28$-8.11
Op Margin-400.9%-360.0%-217.2%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$19.0M$2.0M$5.0M$31.0M
Total Liabilities$6.0M$10.0M$4.0M$2.0M$3.0M
Cash$18.0M$3.0M$0$1.0M$19.0M
Borrowings$2.0M$2.0M$1.0M$0$0

Latest News

Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026 GE Vernova’s AI power trade has one weak link TheStreet · Jul 23, 2026 Flagstar Financial Earnings: What To Look For From FLG StockStory · Jul 23, 2026 Eni and KazMunayGas Reach Key Milestone at Kazakhstan Hybrid Power Plant Oilprice.com · Jul 23, 2026 Stand-On by ABC Display Crowned Best Tradeshow Floor ACCESS Newswire · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-13.0M$-10.0M$-6.0M$-7.0M
Investing Cash Flow$0$-1.0M$4.0M$-2.0M$-16.0M
Financing Cash Flow$0$0$0$0$3.0M
Net Cash Flow$-6.0M$-14.0M$-7.0M$1.0M$18.0M
Free Cash Flow$-15.0M$-14.0M$-10.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA0.05
FCF Yield-181.51%
Quick Ratio11.57
Interest Coverage-16.19
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CMND $1.62 +0.52% -0.79 $2.41M 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%
ENSCEnsysce Biosciences, Inc. $0.26 -1.95% -0.08 $2.38M 0.00%
KALA $0.76 +3.59% -0.76 $14.62M 0.00%

About Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.

Qualigen Therapeutics, Inc. is headquartered in US.

Qualigen Therapeutics, Inc. (QLGN) stock trades at $3.21 with a market capitalization of $5.43M. The stock is valued at a price-to-earnings (P/E) ratio of -0.45, price-to-book of 1.13, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.61 and $8.81, and currently trades 63.6% below its 52-week high.

On profitability, Qualigen Therapeutics, Inc. generates a return on equity (ROE) of -105.92%, return on capital employed of -67.72%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: qlgntx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides